When a Population Average Meets a Person

This chapter diagnoses why studies of coffee and caffeine can diverge even when they appear to ask the same question. The focus is the gap between a population average and a particular exposure: what researchers measured, which differences they could adjust for, and whether the person or product resembles the evidence. The result is a practical audit for interpreting a claim without treating every disagreement as either scientific failure or proof that anything goes.

The study can change the answer before the biology does

When two headlines disagree, the visible symptom is a difference in direction: one says higher coffee intake is associated with more MI, another says it is associated with less stroke, and a third finds no clear link with heart failure. The first diagnostic step is not to choose the more reassuring or alarming headline. It is to ask whether the studies compared the same exposure, outcome, population, and time period.

The updated synthesis is a useful example because its final evidence base was large but observational. It included 33 cohort studies and five case-control studies among 38 studies in total. Cohort studies follow participants and relate reported intake to outcomes that occur later. Case-control studies begin with people who have an outcome and compare their prior exposure with that of people who do not. These designs can reveal patterns across large populations, but they do not randomly assign a fixed amount of coffee or caffeine and observe what would have happened under a different intake.

That distinction matters for causation. Suppose higher coffee intake appears alongside a cardiovascular outcome after researchers adjust for age, smoking, body size, blood pressure, exercise, diet, or other measured factors. The adjustment can make the comparison fairer, but it cannot guarantee that the groups are identical. Some relevant differences may not have been measured, may have been measured imperfectly, or may have been represented differently across studies. The resulting association can be informative while still falling short of proof that coffee or caffeine caused the outcome.

This is residual confounding: the influence of a third factor that remains after the available adjustment. The sources identify baseline cardiovascular risk, lifestyle, genetic factors, coffee type, preparation, and different sets of adjusted variables as possible contributors to context dependence. A person’s consumption can also be embedded in a broader routine. Coffee intake may travel with sleep, work schedule, diet, smoking, alcohol, exercise, or medication use. Adjusting for some of those features does not make the remaining association meaningless, but it does limit how confidently it can be interpreted as the effect of the beverage itself.

The comparator can change the apparent strength of the result as well. The meta-analysis generally compared the highest and lowest intake categories within each study. “High” therefore did not have one fixed meaning. In one dataset it might begin at two cups a day; in another it might refer to four, six, or more. The lowest group might include abstainers, very light drinkers, or people whose consumption pattern differs in other ways. A pooled estimate summarizes those comparisons, but it does not create a single shared threshold.